p18 INK4c/CDKN2C Antibody

About the Target

CDKN2C is a target of interest in many antibody-based workflows. p18 INK4c is a protein that belongs to the INK4 family of cyclin-dependent kinase inhibitors. It acts as a tumor suppressor by inhibiting the activity of CDK4 and CDK6. These CDKs combine with cyclins, such as D-type cyclins, to phosphorylate the retinoblastoma protein, a crucial step for cells to enter the S-phase. p18 INK4c selectively inhibits CDK4/6 activity and consists of 32 amino acid ankyrin motifs. Depending on the literature source, CDKN2C may also be discussed as p18 INK4c/CDKN2C and p18 INK4C.

Reported cellular context includes cytoplasm, cytosol, and nucleus, which can matter when signal is compared across treatments or changing cell states. Following CDKN2C across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

CDKN2C is commonly interpreted in the context of cancer and cell cycle research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm, cytosol, and nucleus, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between cytoplasm, cytosol, and nucleus across matched conditions
• changes associated with proliferative state, oncogenic signaling, or treatment response
• cell-cycle linked differences in abundance, timing, or compartmental enrichment
• co-patterning with orthogonal markers and control conditions that clarify pathway state

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for CDKN2C. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in CDKN2C reflect biology rather than handling. When interpreting CDKN2C, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep CDKN2C trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.